Log in to save to my catalogue

The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Int...

The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Int...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2521818076

The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study

About this item

Full title

The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study

Publisher

New York: Springer US

Journal title

Journal of gastrointestinal surgery, 2021-05, Vol.25 (5), p.1172-1183

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Background and Aims
Surgical resection for patients with intermediate hepatocellular carcinoma (HCC) is preferred in China, but the prognosis remains far from satisfactory. Postoperative transarterial chemoembolization (p-TACE) has been conducted prevalently to prevent recurrence, but its efficacy remains controversial. Hence, we collected the d...

Alternative Titles

Full title

The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2521818076

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2521818076

Other Identifiers

ISSN

1091-255X

E-ISSN

1873-4626

DOI

10.1007/s11605-020-04588-5

How to access this item